Brief: Auris Medical To Develop Kras-Targeting Rna Treatment For Colorectal Cancer As First Therapeutic Indication For Oligophore™ Technology

Altamira Therapeutics

06/07/2021 14:33

July 6 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL TO DEVELOP KRAS-TARGETING RNA TREATMENT FOR
COLORECTAL CANCER AS FIRST THERAPEUTIC INDICATION FOR
OLIGOPHORE™ TECHNOLOGY
    * AURIS MEDICAL HOLDING LTD - TREATMENT OF KRAS-DRIVEN
COLORECTAL
CANCER SELECTED AS FIRST THERAPEUTIC INDICATION FOR OLIGOPHORE™
PLATFORM
    * AURIS MEDICAL HOLDING LTD - COMPANY TO LAUNCH DEVELOPMENT
PROGRAM UNDER PROJECT CODE AM-401 WITH AIM OF IND SUBMISSION IN
LATE 2022

Source text for Eikon:  ID:nGNX5n2rt9 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))